missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CLCNKA Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA536938
This item is not returnable.
View return policy
Description
This antibody detects endogenous protein at a molecular weight of 75 kDa. Purity is >95% by SDS-PAGE.
CLC-KA is a kidney-specific chloride channel that mediates transepithelial chloride transport in the thin ascending limb of the Henle loop in the inner medulla. CLC-KA plays a crucial role in urine concentration. The gene encoding human CLC-KA maps to chromosome 1p36. Mutations in this gene may be associated with nephrogenic diabetes insipidus in those cases where mutations in the vasopressin V2 receptor and the AQP2 water channel are lacking. CLC-KB mediates basolateral chloride ion efflux in the thick ascending limb and in more distal nephron segments. The gene encoding human CLC-KB maps to chromosome 1p36. Mutations in this gene cause type III Barter's syndrome which is characterized by renal salt-wasting and low blood pressure.
Specifications
| CLCNKA | |
| Polyclonal | |
| Unconjugated | |
| CLCNKA | |
| C75963; chloride channel K1; chloride channel Ka; Chloride channel protein ClC-Ka; chloride channel, kidney, A; chloride channel, voltage-sensitive Ka; chloride voltage-gated channel Ka; CLCK1; clC-K1; CLCKA; CLC-KA; Clcnk1; Clcnka; hClC-Ka; putative basolateral cTAL chloride channel ClC-Ka | |
| Rabbit | |
| Antigen Affinity Chromatography | |
| RUO | |
| 1187, 79425 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Western Blot | |
| 1 mg/mL | |
| PBS with 0.05% sodium azide; pH 7.2 | |
| P51800, Q06393 | |
| CLCNKA | |
| Synthetic peptide corresponding to amino acids 626-671 of human CLCNKA. | |
| 100 μL | |
| Primary | |
| Human, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction